SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
This Quarter Return
+5.38%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$407M
AUM Growth
+$407M
(-8.6%)
Cap. Flow
-$50.7M
Cap. Flow
% of AUM
-12.45%
Top 10 Holdings %
Top 10 Hldgs %
19.3%
Holding
282
New
19
Increased
67
Reduced
110
Closed
63
Top Buys
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$7.67M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.16M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$4.24M |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$1.08M |
| 5 |
Zymeworks
ZYME
|
$887K |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$8.83M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$5.78M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$4.57M |
| 4 |
Sangamo Therapeutics
SGMO
|
$1.53M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$966K |
Sector Composition
| 1 | Industrials | 20.92% |
| 2 | Technology | 18% |
| 3 | Healthcare | 15.75% |
| 4 | Materials | 7.84% |
| 5 | Financials | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Prudential Financial
PRU
$38.6B
| $711K | 0.17% |
7,019
+1,541
| +28% | +$156K |
|
152
Fonar
FONR
$101M
| $702K | 0.17% |
28,192
+851
| +3% | +$21.2K |
|
153
RCI Hospitality Holdings
RICK
$324M
| $685K | 0.17% |
23,128
+469
| +2% | +$13.9K |
|
154
Weyerhaeuser
WY
$18.7B
| $681K | 0.17% |
21,088
+975
| +5% | +$31.5K |
|
155
Carnival Corp
CCL
$43.2B
| $647K | 0.16% |
10,139
+191
| +2% | +$12.2K |
|
156
Unum
UNM
$11.9B
| $572K | 0.14% |
14,636
-553
| -4% | -$21.6K |
|
157
Albemarle
ALB
$9.99B
| $566K | 0.14% |
5,677
-512
| -8% | -$51K |
|
158
First Internet Bancorp
INBK
$219M
| $562K | 0.14% |
18,456
+373
| +2% | +$11.4K |
|
159
VSE Corp
VSEC
$3.36B
| $553K | 0.14% |
16,698
+559
| +3% | +$18.5K |
|
160
ManpowerGroup
MAN
$1.96B
| $539K | 0.13% |
6,269
-473
| -7% | -$40.7K |
|
161
Westwood Holdings Group
WHG
$167M
| $531K | 0.13% |
10,255
+448
| +5% | +$23.2K |
|
162
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $528K | 0.13% |
+12,202
| New | +$528K |
|
163
Amazon
AMZN
$2.44T
| $491K | 0.12% |
245
+14
| +6% | +$28.1K |
|
164
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $458K | 0.11% |
5,254
+17
| +0.3% | +$1.48K |
|
165
iShares Russell Mid-Cap ETF
IWR
$44.4B
| $426K | 0.1% |
+1,932
| New | +$426K |
|
166
Rekor Systems
REKR
$141M
| $385K | 0.09% |
+315,625
| New | +$385K |
|
167
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.4B
| $382K | 0.09% |
4,573
-200
| -4% | -$16.7K |
|
168
iShares Short Treasury Bond ETF
SHV
$20.8B
| $314K | 0.08% |
2,841
| – | – |
|
169
Microsoft
MSFT
$3.77T
| $283K | 0.07% |
2,477
| – | – |
|
170
FTI Consulting
FCN
$5.46B
| $280K | 0.07% |
3,830
| – | – |
|
171
Integra LifeSciences
IART
$1.18B
| $263K | 0.06% |
4,000
| – | – |
|
172
Quaker Houghton
KWR
$2.52B
| $243K | 0.06% |
+1,200
| New | +$243K |
|
173
iShares Russell 2000 Growth ETF
IWO
$12.4B
| $220K | 0.05% |
+1,022
| New | +$220K |
|
174
Alibaba
BABA
$322B
| $208K | 0.05% |
1,263
+60
| +5% | +$9.88K |
|
175
Manulife Financial
MFC
$52.2B
| $206K | 0.05% |
11,542
| – | – |
|